No, GLP-1 receptor agonists are not licensed by the MHRA for treating depression and are not included in NICE guidance for managing depressive disorders
These hormone-like substances are the active ingredients in many lash growth serumsnotably, Latisse, which was first introduced as a glaucoma medication
Effect of creatine and beta-alanine supplementation on performance and endocrine responses in strength/power athletes
[1] [7] Other notable effects include injection site reactions beyond pain (erythema, pruritus, induration in 13% of patients), increased heart rate (particularly with liraglutide), gallbladder disease (including gallstones and cholecystitis), and potential dehydration-related acute kidney injury
Plant Physiol 148:536545 Rauser WE, Meuwly P (1995) Retention of cadmium in roots of maize seedlings
Following fixation, the tissue was washed with PBS and then embedded in paraffin